17 October 2017
American Society for Reproductive Medicine grant Professor David Gardner the Distinguished Researcher Award
World leading reproductive science researcher, Professor David Gardner, has become the second Australian to be acknowledged by the American Society for Reproductive Medicine (ASRM), having received the Distinguished Researcher Award for his research and commitment to the field of reproductive biology.
Over the last three decades Professor Gardner, scientific advisor to Melbourne IVF, has made significant contributions to the field of reproductive medicine. These include leading the development and clinical introduction of blastocyst culture, which has transformed how the majority of human in vitro fertilisation cases are performed with use of the ‘Gardner scale’.
“We are extremely proud of David and his achievements. Our collective scientific and medical specialists are constantly inspired by his innovative initiatives and passion, which coincides with our focus on driving advanced solutions to remain at the forefront of fertility treatment” says Virtus Health CEO Sue Channon.
As a clinical scientist, leader, inventor, mentor and citizen to the scientific community, David has authored five of the 100 most cited papers in reproductive medicine and biology. He is ranked number three in the world for impact in his field, subsequently categorising him as one of the most highly cited scientists in reproductive medicine.
“Being recognised by the ASRM is an incredible honour and extremely humbling. I am constantly surrounded by brilliant people, scientists and students, who continually empower me to challenge and rediscover the science of reproductive medicine” says Professor David Gardner.
As a member of the Executive Board and President Elect of the Alpha (Scientists in Reproductive Medicine which is an international society for clinical embryology), David was also recognised by the Australian Academy of Sciences being named a Fellow of the academy in May 2017.
A significant amount of his research has now been translated into current human IVF procedures used around the world, and equally remarkable, his work on the analysis of embryo viability holds great promise for the future.